BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Souk KM, Tamim HM, Abu Daya HA, Rockey DC, Barada KA. Aspirin use for primary prophylaxis: Adverse outcomes in non-variceal upper gastrointestinal bleeding. World J Gastrointest Surg 2016; 8(7): 501-507 [PMID: 27462392 DOI: 10.4240/wjgs.v8.i7.501]
URL: https://www.wjgnet.com/1948-9366/full/v8/i7/501.htm
Number Citing Articles
1
Tai‐ping Wang. Association between TNF‐α polymorphisms and the risk of upper gastrointestinal bleeding induced by aspirin in patients with coronary heart diseaseAnnals of Human Genetics 2019; 83(3): 124 doi: 10.1111/ahg.12295
2
Yangping Zhuang, Shaohuai Xia, Junwei Chen, Jun Ke, Shirong Lin, Qingming Lin, Xiahong Tang, Hanlin Huang, Nan Zheng, Yi Wang, Feng Chen. Construction of a prediction model for rebleeding in patients with acute upper gastrointestinal bleedingEuropean Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01349-3
3
Antonios Wehbeh, Don C. Rockey, Kassem Barada. RE: Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal HemorrhageGastroenterology 2017; 152(3): 669 doi: 10.1053/j.gastro.2016.09.066
4
Fatih Acehan, Buket Karsavuranoğlu, Meryem Aslan, Cagdas Kalkan, Enes Seyda Sahiner, Osman Inan, Mustafa Comoglu, Yusufcan Yilmaz, Ihsan Ates. Improved outcomes in patients with non-variceal upper gastrointestinal bleeding while undergoing antithrombotic therapy: A propensity score matching analysisDigestive and Liver Disease 2024;  doi: 10.1016/j.dld.2024.04.038